A phase-I study of the safety, pharmacokinetics, and antiviral activity of combination didanosine and ribavirin in patients with HIV-1 disease. AIDS Clinical Trials Group 231 Protocol Team.

Source:http://linkedlifedata.com/resource/pubmed/id/8898668

J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1996 Nov 1 13 3 235-46

Download in:

View as

Triples

General Info

PMID
8898668